EUVIMED · CrossrefZeitschrift
Pharmacogenomics
ISSN 1462-2416 · Informa UK Limited
Neueste Artikel
Clinical implementation of pharmacogenetics in inflammatory skin diseases: current evidence and future directions
Prevalence of TPMT and NUDT15 pharmacogenomic variants in a diverse germline testing cohort from India
Genetic determinants of chemotherapy-induced oral mucositis in children with solid malignancies
Global distribution of CYP2C19 variants in clopidogrel-indicated populations: implications for pharmacogenomic-guided antiplatelet therapy
Prescribing prevalence and trends of medications with pharmacogenetic implications: a study based on primary care data in Manitoba, Canada
Organoids for drug sensitivity prediction in urothelial carcinoma
Fall-risk in genetic variable cytochrome P450 enzymes and exposure to anticholinergic drugs – a pilot-analysis from the ADRED-study
From CYP450 pharmacogenomics to personalized medicine: clinical evidence, dosing guidelines, and future perspectives
Mapping the development pipeline of genomic point-of-care tests: a horizon scan
The influence of pharmacogenetics on the treatment-related outcomes of antidepressants and antipsychotics in Brazil: a systematic review
Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases
Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: “It’s no different from your blood type”
The use of cell-free DNA (cfDNA)/circulating tumor DNA (ctDNA) to guide treatment selection in metastatic breast cancer
A review of the existing pharmacogenomic literature of naltrexone for use in alcohol use disorder
The role of NAT2 genetic variants in anti-tuberculosis drug-induced liver injury (AT-DILI): a meta-analysis
Characterizing models for delivery of pharmacogenomic testing: a scoping review
Scoping review of associations between cytochrome P450 3A4/5 single nucleotide polymorphisms and risk factors for fentanyl overdose
Molecular markers of treatment irregularity of statins: influence of polymorphisms in SLCO1B1 and SLCO1B3
From bench to bedside: a spotlight on pharmacogenomics at Nemours Children’s Health
Pharmacogenomics of buprenorphine - a narrative review
The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review
Machine learning models for pharmacogenomic variant effect predictions – recent developments and future frontiers
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN12
Hypertension precision medicine: the promise and pitfalls of pharmacogenomics
Patient perspectives of a multidisciplinary Pharmacogenomics clinic
CYP2C19 and CES1 gene variants affecting clopidogrel metabolism in a South Asian population from Sri Lanka
Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositions
Artificial intelligence, medications, pharmacogenomics, and ethics
Do CYP2D6 genotypes affect oxycodone dose, pharmacokinetics, pain, and adverse effects in cancer?
Effect of UGT1A6 and UGT2B7 polymorphisms on the valproic acid serum concentration and drug-induced liver injury
EUVIMED